Does MAPROTILINE Cause Product use in unapproved indication? 20 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Product use in unapproved indication have been filed in association with MAPROTILINE. This represents 9.6% of all adverse event reports for MAPROTILINE.
20
Reports of Product use in unapproved indication with MAPROTILINE
9.6%
of all MAPROTILINE reports
0
Deaths
15
Hospitalizations
How Dangerous Is Product use in unapproved indication From MAPROTILINE?
Of the 20 reports, 15 (75.0%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MAPROTILINE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does MAPROTILINE Cause?
Constipation (33)
Drug ineffective (31)
Off label use (29)
Conjunctivitis (28)
Intestinal obstruction (28)
Psoriasis (28)
Vision blurred (26)
Dry eye (25)
Mental disorder (25)
Tremor (25)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which MAPROTILINE Alternatives Have Lower Product use in unapproved indication Risk?
MAPROTILINE vs MARALIXIBAT
MAPROTILINE vs MARAVIROC
MAPROTILINE vs MARIBAVIR
MAPROTILINE vs MAVACAMTEN
MAPROTILINE vs MEASLES-MUMPS-RUBELLA VIRUS VACCINE